Association of modifiable risk factors with progression to dementia in relation to amyloid and tau pathology
Addressing modifiable risk factors carries an important potential for reducing the risk of dementia even after the onset of Alzheimer's pathology. Knowledge of biomarker status can further optimize prevention strategies.
Authors
- Zsolt Huszár (ORCID: https://orcid.org/0009-0005-7970-5664)
- Zsolt Molnár (ORCID: https://orcid.org/0000-0002-1468-4058)
- Gábor Csukly (ORCID: https://orcid.org/0000-0002-5006-9407)
- Péter Hegyi (ORCID: https://orcid.org/0000-0002-6443-0259)
- Marie Anne Engh (ORCID: https://orcid.org/0000-0003-4269-5130)
- Francesca Mangialasche (ORCID: https://orcid.org/0000-0002-2686-3926)
- András Horváth (ORCID: https://orcid.org/0000-0002-1769-4892)
- Vanda Koszovácz
- Tamás Terebessy (ORCID: https://orcid.org/0000-0002-7494-6064)
- Alina Solomon (ORCID: https://orcid.org/0000-0002-7166-9903)
- Miia Kivipelto (ORCID: https://orcid.org/0009-0001-1069-1787)
Institutions
- Semmelweis University (HU)
- Poznan University of Medical Sciences (PL)
- Karolinska University Hospital (SE)
- University of Eastern Finland (FI)
- University of Szeged (HU)
- Karolinska Institutet (SE)
- Országos Idegsebészeti Tudományos Intézet (HU)
- Centre for Social Sciences (HU)
- Imperial College London (GB)
- University of Pecs (HU)
- HUN-REN Research Centre for Natural Sciences (HU)
Publication Details
- Journal
- Alzheimer s Research & Therapy
- Published
- 2024-10-26
- DOI
- https://doi.org/10.1186/s13195-024-01602-9
- Citations
- 8
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 3.08
Funders
- EU Joint Programme – Neurodegenerative Disease Research
- Hungarian Scientific Research Fund
- European Research Council